Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomes

Obesity (Silver Spring). 2013 Dec;21(12):2471-80. doi: 10.1002/oby.20437. Epub 2013 Jun 13.

Abstract

Objective: The effects of fructose and glucose consumption on plasma acylation stimulating protein (ASP), adiponectin, and leptin concentrations relative to energy intake, body weight, adiposity, circulating triglycerides, and insulin sensitivity were determined.

Design and methods: Thirty two overweight/obese adults consumed glucose- or fructose-sweetened beverages (25% energy requirement) with their ad libitum diets for 8 weeks, followed by sweetened beverage consumption for 2 weeks with a standardized, energy-balanced diet. Plasma variables were measured at baseline, 2, 8, and 10 weeks, and body adiposity and insulin sensitivity at baseline and 10 weeks.

Results: Fasting and postprandial ASP concentrations increased at 2 and/or 8 weeks. ASP increases correlated with changes in late-evening triglyceride concentrations. At 10 weeks, fasting adiponectin levels decreased in both groups, and decreases were inversely associated with baseline intra-abdominal fat volume. Sugar consumption increased fasting leptin concentrations; increases were associated with body weight changes. The 24-h leptin profiles increased during glucose consumption and decreased during fructose consumption. These changes correlated with changes of 24-h insulin levels.

Conclusions: The consumption of fructose and glucose beverages induced changes in plasma concentrations of ASP, adiponectin, and leptin. Further study is required to determine if these changes contribute to the metabolic dysfunction observed during fructose consumption.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adiponectin / blood*
  • Adiposity
  • Adult
  • Aged
  • Beverages*
  • Blood Glucose / metabolism
  • Body Weight
  • Complement C3
  • Diet
  • Energy Intake
  • Female
  • Fructose / administration & dosage
  • Fructose / adverse effects
  • Humans
  • Insulin / blood
  • Insulin Resistance
  • Intercellular Signaling Peptides and Proteins / blood*
  • Intra-Abdominal Fat / metabolism
  • Leptin / blood*
  • Male
  • Middle Aged
  • Nutritive Sweeteners / administration & dosage
  • Nutritive Sweeteners / adverse effects*
  • Obesity / blood
  • Postmenopause
  • Postprandial Period
  • Triglycerides / blood

Substances

  • Adiponectin
  • Blood Glucose
  • C3 protein, human
  • Complement C3
  • Insulin
  • Intercellular Signaling Peptides and Proteins
  • Leptin
  • Nutritive Sweeteners
  • Triglycerides
  • Fructose